167 Views

Aventa Lymphoma: Robust Genome Wide Fusion and Rearrangement Detection, a Modern Alternative to FISH for Diagnostic Testing

Wednesday, November 12, 2025

1:00 PM - 1:50 PM EST

Location: 157AB, Level 1

Corporate Workshop Speaker(s)

Anthony Schmitt, PhD

SVP of Science
Arima Genomics
Carlsbad, California, United States
Matija Snuderl, MD (he/him/his)

Director of Molecular Pathology
NYU Langone Health
New York, New York, United States
Ying S. Zou, MD, PhD, FACMG (she/her/hers)

Director of Cancer Genetic Laboratory
The Johns Hopkins University
Baltimore, Maryland, United States
Adam C. Smith, PhD, FCCMG, FACMG, erCLG

Clinical Laboratory Director, Cytogenetics
Labcorp

Aventa Lymphoma is a clinically validated lab developed test that leverages Hi-C sequencing to detect all clinically relevant fusions and rearrangements in B- and T-cell lymphomas. This workshop will provide an overview of test technology as well as the clinical experience of three practicing pathologists who have utilized the test, including their results on comparison with clinical FISH, deconvolution of atypical FISH results, and clinical case studies.